Seeking Alpha

Baxter International (BAX) trades 3.8% lower premarket after it discloses along with partner...

Baxter International (BAX) trades 3.8% lower premarket after it discloses along with partner Halozyme Therapeutics that the FDA needs more long-term data on their jointly-developed HyQ product.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector